Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following ...

Astronauts and commercial space travelers are subject to damaging radiation and microgravity, along with other potential injuries. We need better ways to protect them.

Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...

The success of this research will have a profound effect on the lives of millions of people worldwide who are affected by ...

Gene therapy for sickle cell disease remains a tough business model — and may never work, @adamfeuerstein writes.

Back in 2019 and early 2020, bluebird bio stock was between $40 and $50 a share, and the latest quote is 48 cents. This ...

Morgan Conn, Ph.D., seasoned biotech executive with expertise in financing, business development, and corporate strategy, appointed as Chief Financial Officer - - Chad Cowan, Ph.D., cell therapy ...

Spontaneous injuries like the loss of a limb or damage to the spinal cord are impossible for humans to repair. Yet, some ...

In the grand scheme of fish evolution, it makes sense that sea robins would evolve legs that can taste, said Neil Shubin, an evolutionary biologist at the University of Chicago who was not involved in ...

Even gene editing has led to technologies like CRISPR allowing for precise modifications to DNA, potentially curing genetic disorders. The importance of biologics has led to developing therapies ...

The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, ...

The first step in the production chain, performed in a clinic, is to extract some of the patient’s blood and enrich it, a process known as apheresis. This product is purified in the Cell Shuttle. The ...